NASDAQ:LXRX

Lexicon Pharmaceuticals Stock Predictions

etoro logo Buy LXRX
*Your capital is at risk
$1.85
-0.0400 (-2.12%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

LXRX Prediction Chart

LXRX Predictions History

Latest community submissions for LXRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 10, 2026 $1.71 -2.60% $1.72 V 99.66% 5
Apr 10, 2026 $1.73 -1.63% $1.72 V 99.34% 4
Apr 10, 2026 $1.86 +5.68% $1.72 X 91.86% 0
Mar 26, 2026 $1.63 -2.83% $1.63 V 99.85% 6
Mar 26, 2026 $1.65 -1.77% $1.63 V 98.75% 2
Mar 26, 2026 $1.78 +5.95% $1.63 X 90.80% 0
Mar 26, 2026 Bullish $1.63 X 0
Mar 26, 2026 Bullish $1.63 X 0
Mar 25, 2026 $1.67 -2.76% $1.68 V 99.56% 5
Mar 25, 2026 $1.69 -1.72% $1.68 V 99.38% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LXRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LEXICON PHARMACEUTICALS
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The compan...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE